Commentary

Video

4-Year Data for First-Line Nivolumab Plus Chemo in Advanced Gastric/GEJ Cancer

Samuel Cytryn, MD, and David B. Zhen, MD, on 4-year data from CheckMate 649 for nivolumab plus chemotherapy in first-line advanced gastric/GEJ cancer.

Video Player is loading.
Current Time 0:00
Duration 3:08
Loaded: 0%
Stream Type LIVE
Remaining Time 3:08
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected